Support healthcare facilities facing inspections, suspensions, and enforcement action
Act in medical negligence and professional liability matters
Advise pharmaceutical and medical device companies on market entry and compliance
Handle insurer and reimbursement disputes affecting cash flow
Represent healthcare businesses in courts, arbitration, and regulatory proceedings


We advise hospitals and clinics facing inspections, licence suspension, service restrictions, fines, and enforcement action by DHA, DOH, or MOHAP.
We act in claims arising from alleged clinical negligence, treatment outcomes, misdiagnosis, and professional liability exposure involving healthcare providers and insurers.
We support healthcare providers dealing with non-compliance findings, corrective action plans, audits, and regulatory scrutiny threatening continuity of services.
We advise pharmaceutical companies and medical device suppliers on disputes involving approvals, recalls, distribution arrangements, and regulatory compliance failures.
We act in disputes involving insurers and payors over coverage decisions, reimbursement refusals, coding disputes, and delayed payments.
We act for healthcare and life sciences businesses operating under strict regulatory, clinical, and commercial pressure: hospitals, specialist clinics, diagnostic centres, pharmaceutical companies, medical device suppliers, and healthcare investors.
Whether you are delivering clinical services, supplying regulated products, or funding healthcare operations, we focus on protecting your licence, your reputation, and your ability to continue operating when regulatory or dispute risk materialises.

We advise public and private hospitals on licensing, compliance, and disputes that affect clinical operations and institutional reputation.

We represent clinics and diagnostic providers facing regulatory inspections, compliance findings, and professional liability exposure.

We support pharmaceutical businesses on regulatory approvals, distribution disputes, recalls, and compliance with UAE health authorities.



We assess regulatory and clinical exposure early, define a strategy aligned with operational realities, and act decisively through regulatory engagement, negotiation, or dispute resolution.

We have handled hundreds of resolved disputes across regulated and dispute-heavy industries, including healthcare and life sciences.
The matters we advise on are typically:
You tell us what's happening. We review the contracts and correspondence and give you a straight answer on where you stand.
We agree on the objective, the approach, and the fee structure before we start work.
Whether it's negotiation, arbitration, or litigation, we handle the matter directly and keep you informed throughout.
Our goal is resolution, not prolonged billing. We push for outcomes that protect your commercial position.

The UAE medical device market is projected to reach USD 4.71 billion by 2032, but market entry requires navigating MoHAP's rigorous registration process. This guide covers classification requirements, documentation, realistic timelines, fees, and the strategic considerations that determine success in this high-growth market.

An investor-focused guide to licensing healthcare facilities in the UAE, covering regulators, timelines, costs and compliance. Compare DHA, DOH, MOHAP and DHCC requirements and see realistic budgets for clinics, medical centres and day surgery centres.